Report Tools

Global Biotechnology

Published: August 2013 · Publisher: MarketLine
Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017).
Report Type Industry Profiles
Language English
Format Electronic (PDF)
Pages31
Frequency Updated Annually
Availability Will be emailed within 1 business day
Reference No. 0109-6771
Price € 259,00
Options
  • Description
  • Companies Mentioned
  • Table of Contents
  • Ask a Question
Introduction

Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Global biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

*The global biotechnology market had total revenues of $304.0bn in 2012, representing a compound annual growth rate (CAGR) of 9.6% between 2008 and 2012.

*The medical/healthcare segment was the market's most lucrative in 2012, with total revenues of $182.5bn, equivalent to 60.0% of the market's overall value.

*The performance of the market is forecast to decelerate, with an anticipated CAGR of 9% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $468.2bn by the end of 2017.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the global

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalbiotechnology market

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Global biotechnology market with five year forecasts



Key Questions Answered

What was the size of the Global biotechnology market by value in 2012?

What will be the size of the Global biotechnology market in 2017?

What factors are affecting the strength of competition in the Global biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up the global's biotechnology market?
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
#N/A
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 6
Market definition 6
Market analysis 6
Market Data 7
Market value 7
Market Segmentation 8
Category segmentation 8
Geography segmentation 9
Market Outlook 10
Market value forecast 10
Five Forces Analysis 11
Summary 11
Buyer power 12
Supplier power 13
New entrants 14
Threat of substitutes 15
Degree of rivalry 16
Leading Companies 17
Amgen, Inc. 17
Covance Inc. 20
Merck & Co., Inc. 23
F. Hoffmann-La Roche Ltd 26
Appendix 29
Methodology 29
Industry associations 30
Related research 30

LIST OF TABLES
Table 1: Global biotechnology market value: $ billion, 2008–12 7
Table 2: Global biotechnology market category segmentation: $ billion, 2012 8
Table 3: Global biotechnology market geography segmentation: $ billion, 2012 9
Table 4: Global biotechnology market value forecast: $ billion, 2012–17 10
Table 5: Amgen, Inc.: key facts 17
Table 6: Amgen, Inc.: key financials ($) 18
Table 7: Amgen, Inc.: key financial ratios 18
Table 8: Covance Inc.: key facts 20
Table 9: Covance Inc.: key financials ($) 21
Table 10: Covance Inc.: key financial ratios 21
Table 11: Merck & Co., Inc.: key facts 23
Table 12: Merck & Co., Inc.: key financials ($) 24
Table 13: Merck & Co., Inc.: key financial ratios 24
Table 14: F. Hoffmann-La Roche Ltd: key facts 26
Table 15: F. Hoffmann-La Roche Ltd: key financials ($) 27
Table 16: F. Hoffmann-La Roche Ltd: key financials (CHF) 27
Table 17: F. Hoffmann-La Roche Ltd: key financial ratios 27

LIST OF FIGURES
Figure 1: Global biotechnology market value: $ billion, 2008–12 7
Figure 2: Global biotechnology market category segmentation: % share, by value, 2012 8
Figure 3: Global biotechnology market geography segmentation: % share, by value, 2012 9
Figure 4: Global biotechnology market value forecast: $ billion, 2012–17 10
Figure 5: Forces driving competition in the global biotechnology market, 2012 11
Figure 6: Drivers of buyer power in the global biotechnology market, 2012 12
Figure 7: Drivers of supplier power in the global biotechnology market, 2012 13
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology market, 2012 14
Figure 9: Factors influencing the threat of substitutes in the global biotechnology market, 2012 15
Figure 10: Drivers of degree of rivalry in the global biotechnology market, 2012 16
Figure 11: Amgen, Inc.: revenues & profitability 19
Figure 12: Amgen, Inc.: assets & liabilities 19
Figure 13: Covance Inc.: revenues & profitability 21
Figure 14: Covance Inc.: assets & liabilities 22
Figure 15: Merck & Co., Inc.: revenues & profitability 25
Figure 16: Merck & Co., Inc.: assets & liabilities 25
Figure 17: F. Hoffmann-La Roche Ltd: revenues & profitability 28
Figure 18: F. Hoffmann-La Roche Ltd: assets & liabilities 28
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.